Study to Evaluate the Efficacy and Safety of TRL1068 for the Treatment of Prosthetic Joint Infection

NCT06621251 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Prosthetic Joint Infections of Hip
Prosthetic Joint Infections of Knee

Interventions

DRUG: TRL1068 (calpurbatug), a human monoclonal antibody
PROCEDURE: DAIR

Sponsor

Trellis Bioscience LLC